Summary by Futu AI
On February 28, 2024, Pfizer Inc's Executive Vice President, Christoffel Boshoff, completed a transaction involving the company's common stock. Boshoff sold 4,150 shares at a price of $27.04 per share, resulting in a total market value of $112,216. The transaction was part of a payment for exercise price or tax liability by delivering or withholding securities. Additionally, Boshoff acquired 11,510 shares on the same date at no cost, which was reported as a grant, award, or other acquisition. Following these transactions, Boshoff directly holds 156,007 shares of Pfizer common stock. Separately, Boshoff also has an indirect beneficial ownership of 624 shares through a Rule 16b-3 Plan.